Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Retinoic metabolism inhibitors promising against prostate cancer

July 2, 2004

Exelixis submits IND for XL-999

July 2, 2004

FDA accepts IND for MN-029

July 2, 2004

Aplidin receives orphan drug status for ALL

July 2, 2004

Alimta receives positive opinion in Europe

July 1, 2004

Sanofi-Synthelabo and Pfizer conclude agreement on divestment of Campto

July 1, 2004

Preliminary data on Exherin in patients with solid tumors

July 1, 2004

Celecoxib and a poxvirus-based vaccine improve survival in mice with multiple intestinal neoplasia

July 1, 2004

Palifermin NDA submitted for oral mucositis

July 1, 2004

Preclinical progress in DOS-47 development program

June 30, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.